Where Global Innovation
and Capital Meet

iTeos tees up $125m series B2

Apr 6, 2020 • Robert Lavine

The UCL and Ludwig Institute for Cancer Research spinout has collected $125m from investors including existing shareholder Vives Louvain Technology Fund.

iTeos Therapeutics, a US-based immuno-oncology drug spinout of Université catholique de Louvain (UCL) and Ludwig Institute for Cancer Research, completed a $125m series B2 round on Wednesday featuring UCL’s Vives Louvain Technology Fund.
RA Capital Management and Boxer Capital co-led the round, which was also backed by 6 Dimensions Capital, the biotech investment firm co-founded by a subsidiary of pharmaceutical company WuXi AppTec.
Janus Henderson Investors, RTW Investments, Invus, MPM Capital, HBM Partners, Curative Ventures, Fund+, SRIW and…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

More universities adopt investor-friendly IP spinout terms

Academic institutions are taking new approaches to transferring intellectual property rights of university research in a bid to help spinouts attract investors.

Imec.xpand closes Fund II at $320m

The Belgian deep tech venture firm has surpassed its original goal by $50m and more than doubled its assets under management to $455m.

Hong Kong university seeks investors for new $64m fund

The Redbird Innovation Fund will fund spinouts emerging from the Hong Kong university.

Events

Webinar: CVCs and the art of the follow-on

May 8, 2024
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

May 21 -
May 22, 2024
Online

Find out more All events

Events

GCV Symposium 2024

Jun 24 -
Jun 26, 2024
London (UK)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.